Lys-Pro-Val tripeptide derived from alpha-MSH
PRODUCT PROFILE
KPV
Price range: £27.47 through £29.99
KPV is lys-pro-val tripeptide derived from alpha-msh. Researchers examine it in relation to inflammatory signalling in intestinal, skin and immune-cell models.
Why it is distinct
A minimal anti-inflammatory alpha-MSH fragment rather than an antimicrobial peptide such as LL-37.
- Evidence stagePreclinical
- AvailabilityAvailable · select size for stock
- Batch recordOpen COA
- DispatchConfirmed at checkout
SUGGESTED ADD-ONS
Useful additions, clearly shown.
Suggestions are organised by vial format and catalogue context. They are not combined-use guidance or personal-use advice.
-
Specification review
Bacteriostatic Water
Price range: £4.49 through £8.9910 mL | 3 mLBatch file pendingA laboratory supply with two volume variants, not a peptide or biologically active comparison material.
Available · select size for stockAdd to basket This product has multiple variants. The options may be chosen on the product page -
Preclinical
BPC-157
£32.99Batch COA availableBPC-157 is mainly discussed around stomach and local tissue-repair models. TB-500 is instead studied for actin, cell movement…
Available · 30 in stockAdd to basket -
Preclinical
TB-500
£32.99Batch COA availableTB-500 is discussed as a fragment-like repair material, while thymosin beta-4 is the full natural protein and BPC-157…
Available · 30 in stockAdd to basket
PRODUCT INFORMATION
Clear first. Detailed when needed.
What this material is+
KPV is lys-pro-val tripeptide derived from alpha-msh. Researchers examine it in relation to inflammatory signalling in intestinal, skin and immune-cell models.
Research focus+
Researchers study whether it can calm inflammatory activity in gut, skin and immune-cell models. Most evidence is still from laboratory or animal research.
How the mechanism differs+
Studied preclinically for modulation of NF-kB-linked inflammatory responses without reproducing alpha-MSH pigmentation signalling.
Evidence and limitations+
Mostly cell and animal evidence; controlled human evidence for isolated KPV remains very limited.
Testing and batch documentation+
Verified batch documents are available for review.
RESEARCH PROFILE
Understand the distinction.
Researchers study whether it can calm inflammatory activity in gut, skin and immune-cell models. Most evidence is still from laboratory or animal research.
Studied preclinically for modulation of NF-kB-linked inflammatory responses without reproducing alpha-MSH pigmentation signalling.
A minimal anti-inflammatory alpha-MSH fragment rather than an antimicrobial peptide such as LL-37.
Mostly cell and animal evidence; controlled human evidence for isolated KPV remains very limited.
Educational research context only. This information is not dosage, administration or personal-use guidance.
CONTINUE EXPLORING
Related research perspectives.
Selected for useful comparison across neighbouring or contrasting research areas—not as combined-use guidance.
-
Early human evidence
LL-37
£59.005 mgBatch COA availableDirect antimicrobial membrane activity separates it from immune regulators such as KPV or thymosin alpha-1.
UnavailableAsk about availability -
Established
Thymosin Alpha-1
£69.0010 mgBatch COA availableAn immune-response modulator with human clinical literature, distinct from LL-37’s direct antimicrobial activity.
UnavailableAsk about availability